Scandinavian Tobacco Group Acquires Mac Baren Tobacco Co.

Business by 2FIRSTS.ai
Jun.28.2024
Scandinavian Tobacco Group Acquires Mac Baren Tobacco Co.
Danish STG announced acquisition of Mac Baren Tobacco Company, valued at 535 million DKK, to strengthen global tobacco market position.

On June 27th, the Danish tobacco company Scandinavian Tobacco Group (STG) announced on its official website that it has reached terms and conditions with Halberg Company for the acquisition of all shares in its subsidiary, Mac Baren Tobacco Co.

 

The value of this transaction, based on the absence of debt and cash, is 535 million Danish kroner (approximately 76.7 million US dollars). The acquisition will be financed through a combination of cash and debt.

 

Mac Baren Tobacco Company is a family business founded in 1826. It owns brands such as Mac Baren, Amphora, and Holger Danske for pipe tobacco, as well as brands like Amsterdamer, Choice, and Opal for fine-cut tobacco. The company also produces and sells nicotine pouches under the ACE and GRITT brands.

 

Mac Baren's products are sold in 74 countries, with the majority of net sales generated in the United States, Denmark, and Germany. Other key markets include the United Kingdom, France, Spain, and Italy. The company is headquartered in Svendborg, Denmark, and has production facilities in Richmond, Virginia in the United States and Denmark. The company currently has approximately 200 full-time employees.

 

According to a report, Mac Baren achieved a net sales revenue of 723 million Danish kroner (103 million US dollars) in April 2024, with reported EBITDA reaching 85 million Danish kroner. The nicotine pouch business contributed nearly 20% to net sales revenue, but had a slight loss in EBITDA contribution.

 

STG CEO Niels Frederiksen stated:

 

I am pleased that we have taken a significant step in strengthening our tobacco business by acquiring Mac Baren. This acquisition will solidify our presence in the global pipe tobacco market and expand our range of brands that are the most attractive to consumers and meet the highest standards. The integration with our existing business is expected to generate meaningful synergies once fully consolidated, and deliver good value for our shareholders.

 

Chairman of the board of Halberg A/S, Torben Sørensen, stated:

 

The Scandinavian Tobacco Group is acquiring a strong company with a wealth of expertise, beloved brands, and skilled employees. Since its founding in 1826, Mac Baren's core DNA has been focusing on new opportunities and ensuring optimal competitiveness. In light of this, making the company part of a stronger group is a wise move. Ownership will still remain Danish, which is particularly pleasing. This is the best solution for both Mac Baren and Halberg.

 

STG has stated that its full-year financial guidance for 2024 (excluding the impact of acquiring Mac Baren Tobacco Company) remains unchanged. The financial effects of the acquisition will be disclosed immediately after the completion of the integration planning period, which is expected to take up to 120 days. Once fully integrated, the transaction is expected to increase the group's profit margin, earnings per share, and return on investment. If the deal goes through smoothly, the group's leverage ratio (net interest-bearing debt/EBITDA) will temporarily exceed the target ratio of 2.5 times. The transaction will not affect the pending stock buyback plan worth up to 850 million Danish kroner (120 million US dollars).

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
2Firsts First Look|China to End VAT Export Rebates on Vape Devices and Nicotine in April 2027, Following Earlier Removal for HTP Devices and Nicotine Vapes
China's Ministry of Finance and State Taxation Administration announced on October 12, 2026, that value-added tax (VAT) export rebates for vape devices, nicotine and its salts, and certain non-combustible inhalation products will be eliminated from April 1, 2027. The measure adds four tobacco- and nicotine-related customs codes, including 8543400010, which covers vape devices and qualifying empty pods. China previously eliminated rebates for nicotine-containing vaping products and devices under code 8543400090 in April 2026. According to industry classification information held by 2Firsts, the latter currently corresponds to heated tobacco devices. Export excise tax refund and exemption arrangements will remain unchanged.
Special Report
Oct.12
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-Listed Consumer Goods Group Supreme Sees Vape Duty as Potential Consolidation Opportunity, Holds FY27 Outlook
UK-listed consumer goods group Supreme plc says it continues to expect FY27 trading to meet market expectations as the Vaping Products Duty takes effect on October 1, while maintaining a comparatively positive view of the new tax and compliance regime. Supreme has said the framework could increase compliance complexity for smaller operators and contribute to market consolidation, while its manufacturing, compliance and distribution scale may allow it to gain share. Its 88Vape brand will retain its value positioning.
Sep.18
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
Product | SMOORE's VAPORESSO Introduces VAST Refillable Vape With Three Resistances in One Pod
SMOORE-owned vaping brand VAPORESSO introduced the VAST refillable open-system vape in October 2026, featuring Tri-Core Mesh technology that integrates three resistance configurations—0.8Ω, 0.6Ω and 0.4Ω—within a single pod. The device supports different operating modes and e-liquid types. The standard version features a 10mL pod, while a TPD-labelled configuration combines a 2mL pod with an 8mL refill container. The device has a 1,600mAh battery and a maximum output of 30W. VAPORESSO claims up to six pod refills and a tested coil lifespan of up to 150,000 puffs. The UK's MHRA published a related device notification on October 12. The official MSRP is $25.90, compared with a $35.90 listing on VAPORESSO's direct store.
product
Oct.30
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa Sets November 16 Vape Directory Launch: Unlisted Products Face Sales Ban, Manufacturers $1,000 Daily Fines per Product
Iowa plans to publish its first vapor products directory on November 16, 2026, after which products not listed will be prohibited from sale or offer for sale in the state. The Department of Revenue expects to begin penalty enforcement on December 17, following an initial 21-business-day period focused on compliance education. Under House File 2677, retailers, distributors and wholesalers selling unlisted products face civil penalties of $300 per product per day, while manufacturers face $1,000 per product per day. Eligibility extends to FDA-authorized products and certain products meeting historical marketing and pending PMTA requirements. The directory program resumed after a federal appeals court vacated a preliminary injunction in July 2026.
Regulations
Nov.05
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22